Naomi Hartopp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Naomi Hartopp has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Heather Mortiboys
University of Sheffield
4 shared publications - Ada Jimenez-Gonzalez
Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield S10 2TN, United Kingdom
3 shared publications - Andrew James Grierson
Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK
3 shared publications - Catarina Martins Henriques
The University of Sheffield, School of Medicine and Population Health, Bateson Centre, Healthy Lifespan Institute, 2 Sheffield S10 2TN
3 shared publications - Christina Lindsey Hammond
School of Physiology, Pharmacology and Neuroscience University of Bristol Bristol UK
3 shared publications - Michael Rera
Université Paris Cité, CNRS, Functional and Adaptive Biology, UMR8251, Paris, France
3 shared publications
Latest Publications
- Open Access
Identification and small molecule rescue of mitochondrial dysfunction phenotype which converges across Leigh Syndrome and Huntington's Disease patient fibroblasts.
Mitochondrial dysfunction is implicated in a variety of complex neurological disorders. Primary mitochondrial diseases are caused directly by mutations in genes encoding mitochondrial proteins, leading to mitochondrial dysfunction and disease. Mitochondrial dysfunction is also a key contributor to pathogenesis in multiple neurodegenerative diseases. Rescue of mitochondrial function is therefore an attractive therapeutic target in both groups of diseases. In this study, we used primary fibroblasts derived from patients with the primary mitochondrial disease Leigh syndrome (LS) and the neurodegenerative disease Huntington's disease (HD) to investigate mitochondrial phenotypes in these patients. We used these to identify modifiable measures of mitochondrial phenotype using a high content imaging screen. Despite having distinct underlying disease causes, different mitochondrial phenotypes in LS and HD patient derived cells converged on an imbalance between functional and dysfunctional mitochondria. Through multi-parameter screening of the mitochondrial phenotype we identified the AMPK activator A769662 as a small molecule able to rescue this imbalance in both LS and HD patient derived fibroblasts via different pathways. Our findings indicate that high throughput screening for mitochondrial phenotypes could identify novel therapeutic agents to rescue mitochondrial dysfunction in complex neurological disorders.
Open AccessIdentification and small molecule rescue of mitochondrial dysfunction phenotype which converges across Leigh Syndrome and Huntington's Disease patient fibroblasts.
Mitochondrial dysfunction is implicated in a variety of complex neurological disorders. Primary mitochondrial diseases are caused directly by mutations in genes encoding mitochondrial proteins, leading to mitochondrial dysfunction and disease. Mitochondrial dysfunction is also a key contributor to pathogenesis in multiple neurodegenerative diseases. Rescue of mitochondrial function is therefore an attractive therapeutic target in both groups of diseases. In this study, we used primary fibroblasts derived from patients with the primary mitochondrial disease Leigh syndrome (LS) and the neurodegenerative disease Huntington's disease (HD) to investigate mitochondrial phenotypes in these patients. We used these to identify modifiable measures of mitochondrial phenotype using a high content imaging screen. Despite having distinct underlying disease causes, different mitochondrial phenotypes in LS and HD patient derived cells converged on an imbalance between functional and dysfunctional mitochondria. Through multi-parameter screening of the mitochondrial phenotype we identified the AMPK activator A769662 as a small molecule able to rescue this imbalance in both LS and HD patient derived fibroblasts via different pathways. Our findings indicate that high throughput screening for mitochondrial phenotypes could identify novel therapeutic agents to rescue mitochondrial dysfunction in complex neurological disorders.
- Open Access
- 28 October 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70280
Telomerase Depletion Accelerates Ageing of the Zebrafish Brain
Decreased telomerase expression, telomere shortening, senescence‐associated markers, and inflammation have all been independently observed in the ageing brain and associated with disease. However, causality between limited telomerase expression and brain senescence and neuro‐inflammation in the natural ageing setting is yet to be established. Here, we address these questions using the zebrafish as an ageing model. Akin to humans, zebrafish display premature ageing and death in the absence of telomerase and telomere shortening is a driver of cellular senescence. Our work shows for the first time that telomerase deficiency ( tert −/− ) accelerates key hallmarks of ageing identified in the Wild Type (WT) zebrafish brain at transcriptional, cellular, tissue and functional levels. We show that telomerase depletion accelerates ageing‐associated transcriptomic changes associated with dysregulation of stress response and immune genes. These are accompanied by accelerated in situ accumulation of senescence‐associated markers and inflammation in the aged brain. Importantly, in vivo, these changes correlate with increased blood–brain barrier permeability and increased anxiety‐like behaviour. Of note, the acceleration of senescence‐associated markers in the absence of tert occurs not only in the expected proliferative areas but also in non‐proliferative ones, where it is unlikely due to telomere‐dependent replicative exhaustion. This suggests that non‐canonical roles of telomerase may be involved. Together, our work shows that telomerase has a protective role in the zebrafish brain against the accumulation of senescence and neuro‐inflammation and is required for blood–brain barrier integrity.
- 28 October 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70280
Open AccessTelomerase Depletion Accelerates Ageing of the Zebrafish Brain
Decreased telomerase expression, telomere shortening, senescence‐associated markers, and inflammation have all been independently observed in the ageing brain and associated with disease. However, causality between limited telomerase expression and brain senescence and neuro‐inflammation in the natural ageing setting is yet to be established. Here, we address these questions using the zebrafish as an ageing model. Akin to humans, zebrafish display premature ageing and death in the absence of telomerase and telomere shortening is a driver of cellular senescence. Our work shows for the first time that telomerase deficiency ( tert −/− ) accelerates key hallmarks of ageing identified in the Wild Type (WT) zebrafish brain at transcriptional, cellular, tissue and functional levels. We show that telomerase depletion accelerates ageing‐associated transcriptomic changes associated with dysregulation of stress response and immune genes. These are accompanied by accelerated in situ accumulation of senescence‐associated markers and inflammation in the aged brain. Importantly, in vivo, these changes correlate with increased blood–brain barrier permeability and increased anxiety‐like behaviour. Of note, the acceleration of senescence‐associated markers in the absence of tert occurs not only in the expected proliferative areas but also in non‐proliferative ones, where it is unlikely due to telomere‐dependent replicative exhaustion. This suggests that non‐canonical roles of telomerase may be involved. Together, our work shows that telomerase has a protective role in the zebrafish brain against the accumulation of senescence and neuro‐inflammation and is required for blood–brain barrier integrity.
- Open Access
TELOMERASE DEPLETION ACCELERATES AGEING OF THE ZEBRAFISH BRAIN
Decreased telomerase expression, telomere shortening, senescence-associated markers and inflammation have all been independently observed in the ageing brain and associated with disease. However, causality between limited telomerase expression and brain senescence and neuro-inflammation in the natural ageing setting is yet to be established. Here, we address these questions using the zebrafish as an ageing model which. Akin to humans, zebrafish display premature ageing and death in the absence of telomerase and where telomere shortening is a driver of cellular senescence. Our work shows for the first time that telomerase deficiency ( tert -/- ) accelerates key hallmarks of ageing identified in the Wild Type (WT) zebrafish brain at transcriptional, cellular, tissue and functional levels. We show that telomerase depletion accelerates ageing-associated transcriptomic changes associated with dysregulation of stress response and immune genes. These are accompanied by accelerated in situ accumulation of senescence-associated markers and inflammation in the aged brain. Importantly, In vivo , these changes correlate with increased blood-brain barrier permeability and increased anxiety-like behaviour. Of note, the acceleration of senescence-associated markers in the absence of tert occurs not only in the expected proliferative areas but also in non-proliferative ones, where it is unlikely due to telomere-dependent replicative exhaustion, suggesting that non-canonical roles of telomerase may be involved. Together, our work suggests that telomerase has a protective role in the zebrafish brain against the accumulation of senescence and neuro-inflammation and is required for blood-brain barrier integrity. GRAPHICAL Graphical Telomerase depletion accelerates markers of ageing in the zebrafish brain, ranging from dysregulated immune and stress ageing transcriptomic hallmarks to in situ accumulation of senescence-associated markers and inflammation, dysfunction of the blood-brain barrier and increased anxiety behaviour.
Open AccessTELOMERASE DEPLETION ACCELERATES AGEING OF THE ZEBRAFISH BRAIN
Decreased telomerase expression, telomere shortening, senescence-associated markers and inflammation have all been independently observed in the ageing brain and associated with disease. However, causality between limited telomerase expression and brain senescence and neuro-inflammation in the natural ageing setting is yet to be established. Here, we address these questions using the zebrafish as an ageing model which. Akin to humans, zebrafish display premature ageing and death in the absence of telomerase and where telomere shortening is a driver of cellular senescence. Our work shows for the first time that telomerase deficiency ( tert -/- ) accelerates key hallmarks of ageing identified in the Wild Type (WT) zebrafish brain at transcriptional, cellular, tissue and functional levels. We show that telomerase depletion accelerates ageing-associated transcriptomic changes associated with dysregulation of stress response and immune genes. These are accompanied by accelerated in situ accumulation of senescence-associated markers and inflammation in the aged brain. Importantly, In vivo , these changes correlate with increased blood-brain barrier permeability and increased anxiety-like behaviour. Of note, the acceleration of senescence-associated markers in the absence of tert occurs not only in the expected proliferative areas but also in non-proliferative ones, where it is unlikely due to telomere-dependent replicative exhaustion, suggesting that non-canonical roles of telomerase may be involved. Together, our work suggests that telomerase has a protective role in the zebrafish brain against the accumulation of senescence and neuro-inflammation and is required for blood-brain barrier integrity. GRAPHICAL Graphical Telomerase depletion accelerates markers of ageing in the zebrafish brain, ranging from dysregulated immune and stress ageing transcriptomic hallmarks to in situ accumulation of senescence-associated markers and inflammation, dysfunction of the blood-brain barrier and increased anxiety behaviour.
- Open Access
- 23 March 2022
- Published by Elsevier in Neuroscience Applied
- Vol. 1, 100027
Serum from older adults increases apoptosis and molecular ageing markers in human hippocampal progenitor cells
- 23 March 2022
- Published by Elsevier in Neuroscience Applied
- Vol. 1, 100027
Open AccessSerum from older adults increases apoptosis and molecular ageing markers in human hippocampal progenitor cells
- Open Access
- 1 September 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 143, 105020
Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain
- 1 September 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 143, 105020
Open AccessDisruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain